Published in J Stroke on May 30, 2014
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation (ARISTOTLE) | NCT00412984
A Phase III Study of Apixaban in Patients With Atrial Fibrillation (AVERROES) | NCT00496769
Secondary Prevention of Venous Thrombo Embolism (VTE). (RE-MEDY) | NCT00329238
The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society. Korean Circ J (2015) 0.82
Traditional Risk Factors for Stroke in East Asia. J Stroke (2016) 0.77
The primary goal of anticoagulation in atrial fibrillation to prevent stroke and not to offer the apparently cheapest treatment. J Stroke (2014) 0.75
Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants. J Stroke (2016) 0.75
Amiodarone use is associated with increased risk of stroke in patients with nonvalvular atrial fibrillation: a nationwide population-based cohort study. Medicine (Baltimore) (2015) 0.75
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet (2013) 12.44
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med (2005) 8.77
Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2013) 7.70
Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ (2009) 6.23
Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score. Chest (2013) 4.71
Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –. Circ J (2012) 3.70
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. JAMA (2005) 3.54
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. Pharmacogenet Genomics (2006) 2.66
Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke (2013) 2.52
Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol (2007) 2.41
Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology (2006) 2.38
Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost (2011) 2.35
Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 2.17
Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial. Ann Intern Med (2011) 1.98
Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology (2002) 1.82
Safety and efficacy of the oral direct factor xa inhibitor apixaban in Japanese patients with non-valvular atrial fibrillation. -The ARISTOTLE-J study-. Circ J (2011) 1.79
Health care and consumer choice: medical and alternative therapies. Soc Sci Med (1997) 1.77
Incidence of the major stroke subtypes: initial findings from the North East Melbourne stroke incidence study (NEMESIS). Stroke (2001) 1.69
Persistence with therapy among patients treated with warfarin for atrial fibrillation. Arch Intern Med (2012) 1.65
Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke (2002) 1.62
Admission international normalized ratio and acute infarct volume in ischemic stroke. Ann Neurol (2008) 1.50
Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation. Stroke (2013) 1.37
Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages. Neurology (2003) 1.17
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack. Stroke (2012) 1.15
Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol (2012) 1.14
Stroke prevention in atrial fibrillation: an Asian perspective. Thromb Haemost (2014) 1.13
Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients. Clin Pharmacol Ther (2003) 1.10
Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version. Circ J (2010) 1.07
Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation. Neurology (2012) 1.05
Risk of hemorrhagic stroke in Asian American ethnic groups. Neuroepidemiology (2005) 1.02
Use of herbal medicines by patients receiving warfarin. Drug Saf (2003) 0.98
Predicting the quality of anticoagulation during warfarin therapy: the basis for an individualized approach. Chest (2013) 0.83
The clinical implications of new oral anticoagulants: will the potential advantages be achieved? Thromb Haemost (2009) 0.79
The determinants of stroke phenotypes were different from the predictors (CHADS2 and CHA2DS2-VASc) of stroke in patients with atrial fibrillation: a comprehensive approach. BMC Neurol (2011) 0.78
Facilitating Stroke Management using Modern Information Technology. J Stroke (2013) 1.14
Endovascular Recanalization Therapy in Acute Ischemic Stroke: Updated Meta-analysis of Randomized Controlled Trials. J Stroke (2015) 1.01
Intracranial atherosclerosis: current understanding and perspectives. J Stroke (2014) 1.00
MRI-based Algorithm for Acute Ischemic Stroke Subtype Classification. J Stroke (2014) 0.93
Multimodal MRI for ischemic stroke: from acute therapy to preventive strategies. J Clin Neurol (2009) 0.89
Symptomatic steno-occlusion in patients with acute cerebral infarction: prevalence, distribution, and functional outcome. J Stroke (2014) 0.86
Adult Moyamoya Disease: A Burden of Intracranial Stenosis in East Asians? PLoS One (2015) 0.84
Predicting stroke outcome using clinical- versus imaging-based scoring system. J Stroke Cerebrovasc Dis (2014) 0.83
Patent Foramen Ovale and Stroke-Current Status. J Stroke (2015) 0.83
Repeated thrombolytic therapy in patients with recurrent acute ischemic stroke. J Stroke (2013) 0.82
The iScore predicts clinical response to tissue plasminogen activator in Korean stroke patients. J Stroke Cerebrovasc Dis (2013) 0.82
Process improvement to enhance existing stroke team activity toward more timely thrombolytic treatment. J Clin Neurol (2014) 0.82
Effect and Safety of Rosuvastatin in Acute Ischemic Stroke. J Stroke (2016) 0.80
Low levels of plasma omega 3-polyunsaturated fatty acids are associated with cerebral small vessel diseases in acute ischemic stroke patients. Nutr Res (2015) 0.80
Updated Korean Clinical Practice Guidelines on Decompressive Surgery for Malignant Middle Cerebral Artery Territory Infarction. J Stroke (2015) 0.80
Rationale and design of Triple AXEL: trial for early anticoagulation in acute ischemic stroke patients with nonvalvular atrial fibrillation. Int J Stroke (2014) 0.79
Distribution of cerebral microbleeds determines their association with impaired kidney function. J Clin Neurol (2014) 0.79
Hypercoagulability and Mortality of Patients with Stroke and Active Cancer: the OASIS-CANCER Study. J Stroke (2016) 0.79
Modest blood pressure reduction with valsartan in acute ischemic stroke: a prospective, randomized, open-label, blinded-end-point trial. Int J Stroke (2015) 0.78
Clinical practice guidelines for the medical and surgical management of primary intracerebral hemorrhage in Korea. J Korean Neurosurg Soc (2014) 0.78
Computed Tomography-Based Thrombus Imaging for the Prediction of Recanalization after Reperfusion Therapy in Stroke. J Stroke (2017) 0.78
Recurrent Cardioembolic Stroke Treated Successfully with Repeated Mechanical Thrombectomy within the Acute Index Stroke Period. J Clin Neurol (2014) 0.77
Long-term mortality in patients with coexisting potential causes of ischemic stroke. Int J Stroke (2013) 0.77
Long-term mortality according to the characteristics of early neurological deterioration in ischemic stroke patients. Yonsei Med J (2014) 0.77
Incremental Value of Left Atrial Global Longitudinal Strain for Prediction of Post Stroke Atrial Fibrillation in Patients with Acute Ischemic Stroke. J Cardiovasc Ultrasound (2016) 0.77
Update of the Korean Clinical Practice Guidelines for Endovascular Recanalization Therapy in Patients with Acute Ischemic Stroke. J Stroke (2016) 0.77
Simple Estimates of Symptomatic Intracranial Hemorrhage Risk and Outcome after Intravenous Thrombolysis Using Age and Stroke Severity. J Stroke (2017) 0.77
Physicians' attitudes toward guidelines for stroke: a survey of korean neurologists. J Stroke (2014) 0.76
Lack of Association of Clinical Factors (SAMe-TT2R2) with CYP2C9/VKORC1 Genotype and Anticoagulation Control Quality. J Stroke (2015) 0.76
Impact of temporary opening using a stent retriever on clinical outcome in acute ischemic stroke. PLoS One (2015) 0.75
Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants. J Stroke (2016) 0.75
Gray-Matter Volume Estimate Score: A Novel Semi-Automatic Method Measuring Early Ischemic Change on CT. J Stroke (2015) 0.75
Decision-Making Support Using a Standardized Script and Visual Decision Aid to Reduce Door-to-Needle Time in Stroke. J Stroke (2016) 0.75
Prestroke Antiplatelet Effect on Symptomatic Intracranial Hemorrhage and Functional Outcome in Intravenous Thrombolysis. J Stroke (2016) 0.75
Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography. PLoS One (2015) 0.75
Association between Aortic Atheroma and Cerebral Small Vessel Disease in Patients with Ischemic Stroke. J Stroke (2016) 0.75
The Computerized Table Setting Test for Detecting Unilateral Neglect. PLoS One (2016) 0.75
Role of high-resolution magnetic resonance imaging in the diagnosis of primary angiitis of the central nervous system. J Clin Neurol (2014) 0.75
Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke. J Stroke (2015) 0.75
Total Cerebral Small-Vessel Disease Score is Associated with Mortality during Follow-Up after Acute Ischemic Stroke. J Clin Neurol (2017) 0.75
Response to letter regarding article, "high-resolution magnetic resonance wall imaging findings of Moyamoya disease". Stroke (2014) 0.75
Association of Left Atrial Enlargement with Cortical Infarction in Subjects with Patent Foramen Ovale. J Stroke (2016) 0.75
Low-density-lipoprotein particle size predicts a poor outcome in patients with atherothrombotic stroke. J Clin Neurol (2015) 0.75
Endovascular Therapy: The Second Round Begins. J Stroke (2017) 0.75
Blood Pressure Management for Stroke Prevention and in Acute Stroke. J Stroke (2017) 0.75
Value of utilizing both ASPECTS and CT angiography collateral score for outcome prediction in acute ischemic stroke. Int J Stroke (2015) 0.75
Thrombus length discrepancy on dual-phase CT can predict clinical outcome in acute ischemic stroke. Eur Radiol (2015) 0.75
High-Resolution Intracranial Vessel Wall MRI Findings Among Different Middle Cerebral Artery Territory Infarction Types. Korean J Radiol (2022) 0.75
Association of Systolic Blood Pressure with Progression of Symptomatic Intracranial Atherosclerotic Stenosis. J Stroke (2017) 0.75
Recanalization therapy for internal carotid artery occlusion presenting as acute ischemic stroke. J Stroke Cerebrovasc Dis (2014) 0.75
Quality of Anticoagulation with Warfarin in Korean Patients with Atrial Fibrillation and Prior Stroke: A Multicenter Retrospective Observational Study. J Clin Neurol (2017) 0.75
Histopathological Findings of Intracranial Thrombi in Nonbacterial Thrombotic Endocarditis. J Stroke (2017) 0.75
Timely Interventions can Increase Smoking Cessation Rate in Men with Ischemic Stroke. J Korean Acad Nurs (2016) 0.75
Medical Treatment of Intracranial Atherosclerosis: An Update. J Stroke (2017) 0.75
Current status of recanalization therapy in acute ischemic stroke with symptomatic intracranial arterial occlusion in Korea. J Stroke Cerebrovasc Dis (2014) 0.75